skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Result Number Material Type Add to My Shelf Action Record Details and Options
1
In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation
In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation
Material Type:
Article 		Add to My Research

In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation

PloS one, 2021-02, Vol.16 (2), p.e0245772-e0245772 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;COPYRIGHT 2021 Public Library of Science ;2021 Olivas-Martínez et al 2021 Olivas-Martínez et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0245772 ;PMID: 33534813

Full text available

Citations Cited by
2
Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center
Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center
Material Type:
Article 		Add to My Research

Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center

Revista de investigacion clinica, 2022-01, Vol.74 (1), p.40-50 [Peer Reviewed Journal]

ISSN: 0034-8376 ;EISSN: 2564-8896 ;DOI: 10.24875/RIC.21000404 ;PMID: 34618802

Full text available

Citations Cited by
3
Predictors of poor outcomes in young non-comorbid patients with COVID-19
Predictors of poor outcomes in young non-comorbid patients with COVID-19
Material Type:
Article 		Add to My Research

Predictors of poor outcomes in young non-comorbid patients with COVID-19

Revista de investigacion clinica, 2022, Vol.74 (5), p.268-275 [Peer Reviewed Journal]

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. ;ISSN: 0034-8376 ;ISSN: 2564-8896 ;EISSN: 2564-8896 ;DOI: 10.24875/RIC.22000162

Full text available

Citations Cited by
4
Delivering acute stroke care in a middle-income country. The Mexican model: "ResISSSTE Cerebro"
Delivering acute stroke care in a middle-income country. The Mexican model: "ResISSSTE Cerebro"
Material Type:
Article 		Add to My Research

Delivering acute stroke care in a middle-income country. The Mexican model: "ResISSSTE Cerebro"

Frontiers in neurology, 2023-02, Vol.14, p.1103066-1103066 [Peer Reviewed Journal]

Copyright © 2023 Bonifacio-Delgadillo, Castellanos-Pedroza, Martínez-Guerra, Sánchez-Martínez and Marquez-Romero. ;Copyright © 2023 Bonifacio-Delgadillo, Castellanos-Pedroza, Martínez-Guerra, Sánchez-Martínez and Marquez-Romero. 2023 Bonifacio-Delgadillo, Castellanos-Pedroza, Martínez-Guerra, Sánchez-Martínez and Marquez-Romero ;ISSN: 1664-2295 ;EISSN: 1664-2295 ;DOI: 10.3389/fneur.2023.1103066 ;PMID: 36908627

Full text available

Citations Cited by
5
Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients With COVID-19-Induced Acute Respiratory Distress Syndrome
Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients With COVID-19-Induced Acute Respiratory Distress Syndrome
Material Type:
Article 		Add to My Research

Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients With COVID-19-Induced Acute Respiratory Distress Syndrome

Critical care explorations, 2022-04, Vol.4 (4), p.e0668-e0668 [Peer Reviewed Journal]

Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. ;Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. 2022 ;ISSN: 2639-8028 ;EISSN: 2639-8028 ;DOI: 10.1097/CCE.0000000000000668 ;PMID: 35372841

Full text available

Citations Cited by
6
Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation
Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation
Material Type:
Article 		Add to My Research

Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation

PloS one, 2022-05, Vol.17 (5), p.e0269053-e0269053 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 Olivas-Martínez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Olivas-Martínez et al 2022 Olivas-Martínez et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0269053 ;PMID: 35604924

Full text available

Citations Cited by
7
Large scale screening for SARS-CoV-2 among healthcare workers: prevalence and risk factors for asymptomatic/pauci-symptomatic carriers, with emphasis on PPE use
Large scale screening for SARS-CoV-2 among healthcare workers: prevalence and risk factors for asymptomatic/pauci-symptomatic carriers, with emphasis on PPE use
Material Type:
Article 		Add to My Research

Large scale screening for SARS-CoV-2 among healthcare workers: prevalence and risk factors for asymptomatic/pauci-symptomatic carriers, with emphasis on PPE use

Infection Control & Hospital Epidemiology, 2021-02, p.1 [Peer Reviewed Journal]

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.stm-assoc.org/about-the-industry/coronavirus-2019-ncov/. ;DOI: 10.1017/ice.2021.68

Digital Resources/Online E-Resources

Citations Cited by
8
Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study
Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study
Material Type:
Article 		Add to My Research

Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study

Emerging microbes & infections, 2022-12, Vol.11 (1), p.50-59 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2021 The Author(s) ;ISSN: 2222-1751 ;EISSN: 2222-1751 ;DOI: 10.1080/22221751.2021.2011619 ;PMID: 34839785

Full text available

Citations Cited by
9
Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic
Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic
Material Type:
Article 		Add to My Research

Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic

Antibiotics (Basel), 2021-02, Vol.10 (2), p.182 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2079-6382 ;EISSN: 2079-6382 ;DOI: 10.3390/antibiotics10020182 ;PMID: 33670316

Full text available

Citations Cited by
10
Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study
Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study
Material Type:
Article 		Add to My Research

Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study

Antibiotics (Basel), 2024-02, Vol.13 (2), p.176 [Peer Reviewed Journal]

2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2079-6382 ;EISSN: 2079-6382 ;DOI: 10.3390/antibiotics13020176 ;PMID: 38391562

Full text available

Citations Cited by
11
Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City
Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City
Material Type:
Article 		Add to My Research

Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City

Frontiers in pharmacology, 2021-06, Vol.12, p.668678-668678 [Peer Reviewed Journal]

Copyright © 2021 Lozano-Cruz, Jiménez, Olivas-Martinez, Ortiz-Brizuela, Cárdenas-Fragoso, Azamar-Llamas, Rodríguez-Rodríguez, Oseguera-Moguel, Dorantes-García, Barrón-Magdaleno, Cázares-Diazleal, Román-Montes, Tamez-Torres, Martínez-Guerra, Gulias-Herrero, González-Lara, Ponce-de-León-Garduño, Kershenobich-Stalnikowitz and Sifuentes-Osornio. 2021 Lozano-Cruz, Jiménez, Olivas-Martinez, Ortiz-Brizuela, Cárdenas-Fragoso, Azamar-Llamas, Rodríguez-Rodríguez, Oseguera-Moguel, Dorantes-García, Barrón-Magdaleno, Cázares-Diazleal, Román-Montes, Tamez-Torres, Martínez-Guerra, Gulias-Herrero, González-Lara, Ponce-de-León-Garduño, Kershenobich-Stalnikowitz and Sifuentes-Osornio ;ISSN: 1663-9812 ;EISSN: 1663-9812 ;DOI: 10.3389/fphar.2021.668678 ;PMID: 34149420

Full text available

Citations Cited by
12
Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study
Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study
Material Type:
Article 		Add to My Research

Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study

Therapeutic advances in infectious disease, 2024-01, Vol.11 [Peer Reviewed Journal]

The Author(s), 2024 2024 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2049-9361 ;EISSN: 2049-937X ;DOI: 10.1177/20499361241236582

Full text available

Citations Cited by
13
Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico
Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico
Material Type:
Article 		Add to My Research

Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico

Journal of fungi (Basel), 2023-05, Vol.9 (5), p.583 [Peer Reviewed Journal]

2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2309-608X ;EISSN: 2309-608X ;DOI: 10.3390/jof9050583 ;PMID: 37233294

Full text available

Citations Cited by
14
Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study
Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study
Material Type:
Article 		Add to My Research

Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study

Open forum infectious diseases, 2022-10, Vol.9 (10), p.ofac502-ofac502 [Peer Reviewed Journal]

COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2022 ;ISSN: 2328-8957 ;EISSN: 2328-8957 ;DOI: 10.1093/ofid/ofac502

Full text available

Citations Cited by
15
Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
Material Type:
Article 		Add to My Research

Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria

Antibiotics (Basel), 2023-06, Vol.12 (7), p.1130 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2079-6382 ;EISSN: 2079-6382 ;DOI: 10.3390/antibiotics12071130 ;PMID: 37508226

Full text available

Citations Cited by
16
Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19
Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19
Material Type:
Article 		Add to My Research

Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19

Antibiotics (Basel), 2023-06, Vol.12 (7), p.1108 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2079-6382 ;EISSN: 2079-6382 ;DOI: 10.3390/antibiotics12071108 ;PMID: 37508204

Full text available

Citations Cited by
17
Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation
Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation
Material Type:
Article 		Add to My Research

Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation

PloS one, 2022-01, Vol.17 (5) [Peer Reviewed Journal]

EISSN: 1932-6203

Full text available

Citations Cited by
18
Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible IStaphylococcus aureus/I Bacteraemia: A Retrospective Cohort Study
Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible IStaphylococcus aureus/I Bacteraemia: A Retrospective Cohort Study
Material Type:
Article 		Add to My Research

Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible IStaphylococcus aureus/I Bacteraemia: A Retrospective Cohort Study

Antibiotics (Basel), 2024-02, Vol.13 (2) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2079-6382 ;EISSN: 2079-6382 ;DOI: 10.3390/antibiotics13020176

Full text available

Citations Cited by
19
Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in IEscherichia coli, Klebsiella pneumoniae/I and IPseudomonas aeruginosa/I
Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in IEscherichia coli, Klebsiella pneumoniae/I and IPseudomonas aeruginosa/I
Material Type:
Article 		Add to My Research

Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in IEscherichia coli, Klebsiella pneumoniae/I and IPseudomonas aeruginosa/I

Diagnostics (Basel), 2023-11, Vol.13 (22) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2075-4418 ;EISSN: 2075-4418 ;DOI: 10.3390/diagnostics13223417

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait